Literature DB >> 14621735

Renal retransplantation in Switzerland: poor HLA matching of first and subsequent allografts does not appear to affect overall graft survival.

T Etienne1, C Goumaz, P Ruedin, M Jeannet.   

Abstract

In Switzerland graft survival after primary renal transplantation can be considered as satisfactory, although our current policy does not favour HLA compatibility except for acute rejectors or sensitized patients. This low level of HLA matching could result in increased sensitization and affect subsequent graft survival. A total of 318 non-primary renal transplants were performed in 293 recipients during the period 1981-1990. Of these, 271 were second transplants, 40 were third transplants and seven were fourth or fifth transplants. Survival rates at 1, 2 and 5 years were 75%, 68% and 60% for second grafts, and 72%, 60% and 54% for third grafts, respectively. Results after multiple grafts were poor, but our experience was limited. The number of sensitized patients (peak PRA > 50%) awaiting retransplantation slightly increased (51 to 69), but decreased as a proportion (72% to 66%). Our policy of relying only marginally on HLA compatibility does not appear to have affected our results adversely.

Entities:  

Mesh:

Year:  1992        PMID: 14621735     DOI: 10.1007/978-3-642-77423-2_21

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  2 in total

1.  Early steroid withdrawal in repeat kidney transplantation.

Authors:  Muhammad A Mujtaba; Tim E Taber; William C Goggins; Muhammad S Yaqub; Dennis P Mishler; Martin L Milgrom; Jonathan A Fridell; Andrew Lobashevsky; John A Powelson; Asif A Sharfuddin
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-04       Impact factor: 8.237

2.  Long-term outcome of third, fourth and fifth kidney transplantation: technical aspects and immunological challenges.

Authors:  Tamas Benkö; Patrizia Halfmann; Anja Gäckler; Sonia Radünz; Jürgen W Treckmann; Gernot M Kaiser; Dieter P Hoyer
Journal:  Clin Kidney J       Date:  2019-02-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.